Neoadjuvant treatment for resectable pancreatic adenocarcinoma: What is the best protocol?
Abstract Although upfront surgery has been the gold standard for pancreatic adenocarcinoma that is planned for resection, it should be compared with the alternative strategy of neoadjuvant therapy. Despite the many reports of the efficacy of neoadjuvant therapy, most of them were not comparative. Re...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wiley
2020-03-01
|
| Edice: | Annals of Gastroenterological Surgery |
| Témata: | |
| On-line přístup: | https://doi.org/10.1002/ags3.12311 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|